Autoimmune Disease Therapeutics Market Share Soaring 4.2% CAGR to Register 153,320 Million by 2025

Portland, April 25, 2019 (GLOBE NEWSWIRE) -- An autoimmune disease is a condition in which the immune system mistakenly attacks and damages its own tissues. There are more than 80 different autoimmune diseases exist. Some of the common types of autoimmune diseases are rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, systemic lupus erythematosus (lupus), inflammatory bowel disease, and others.

The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.

Get a Research Sample Copy: https://www.bigmarketresearch.com/request-sample/2955688

Autoimmune disease therapeutics are expected to experience significant market growth during the forecast period owing to early diagnosis of the disease, recent launch of advanced therapeutics, and rise in incidence of autoimmune disease. Furthermore, strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other side higher cost associated with the advanced therapeutics is expected to hamper the market growth.

The global autoimmune disease therapeutics market is segmented based on drug class, indication, sales channel, and region. Based on drug class, the market is classified as anti-inflammatory, antihyperglycemics, NSAIDs, interferons, and others. On the basis of indication, rheumatic disease, type 1 diabetes, multiple sclerosis, rare disease, inflammatory bowel disease, and other indications. According to the sales channel, the market is categorized as hospital pharmacy, drug stores & retail pharmacy, and online store. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, and rest of LAMEA).

List of key players profiled in the report are Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, Pfizer Inc. and UCB S.A.

Request a Discount: https://www.bigmarketresearch.com/request-for-discount/2955688

List of other players in the value chain (These players are not profiled in the report. The same will be included on request.) Biogen Inc., EMD Serono Inc., GlaxoSmithKline plc, Shire Plc. and Teva Pharmaceutical Industries Ltd.

Related Report:

Global Digital Therapeutics Market Size Study by Application, By Product and Regional Forecasts 2018-2025

Global Cancer Therapeutics Market Research Report 2019

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

Contact us: 
Mr. Abhishek Paliwal
Big Market Research
5933 NE Win Sivers Drive, #205, Portland, 
OR 97220 United States
Direct: +1-971-202-1575
Toll Free: +1-800-910-6452
E-mail: help@bigmarketresearch.com